Alvarez, Sugala S.
HRN: 22-17-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/10/2022
11/16/2022
IV
600mg
Q6
Fungating Mass
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes